Total Payments
$24,926
2024 Payments
$2,212
Companies
23
Transactions
85
Medicare Patients
1,952
Medicare Billing
$251,894
Payment Breakdown by Category
Consulting$16,688 (66.9%)
Other$6,638 (26.6%)
Food & Beverage$1,435 (5.8%)
Education$165.38 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $16,688 | 16 | 66.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $5,138 | 2 | 20.6% |
| Honoraria | $1,500 | 1 | 6.0% |
| Food and Beverage | $1,435 | 60 | 5.8% |
| Education | $165.38 | 6 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $10,515 | 19 | $0 (2024) |
| Verastem, Inc. | $5,162 | 2 | $0 (2019) |
| Karyopharm Therapeutics Inc. | $2,250 | 1 | $0 (2021) |
| AbbVie Inc. | $2,200 | 1 | $0 (2021) |
| Siemens Medical Solutions USA, Inc. | $2,000 | 5 | $0 (2024) |
| Secura Bio, Inc. | $1,598 | 2 | $0 (2020) |
| Celgene Corporation | $310.56 | 19 | $0 (2024) |
| Exelixis Inc. | $165.05 | 5 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $145.56 | 3 | $0 (2018) |
| Amgen Inc. | $105.51 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,212 | 18 | AstraZeneca Pharmaceuticals LP ($1,221) |
| 2023 | $5,521 | 29 | AstraZeneca Pharmaceuticals LP ($3,935) |
| 2022 | $1,272 | 15 | AstraZeneca Pharmaceuticals LP ($1,020) |
| 2021 | $5,860 | 6 | Karyopharm Therapeutics Inc. ($2,250) |
| 2020 | $4,588 | 6 | AstraZeneca Pharmaceuticals LP ($2,973) |
| 2019 | $5,174 | 3 | Verastem, Inc. ($5,162) |
| 2018 | $14.46 | 1 | Merck Sharp & Dohme Corporation ($14.46) |
| 2017 | $284.19 | 7 | Exelixis Inc. ($141.69) |
All Payment Transactions
85 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $13.27 | General |
| 11/21/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $1.47 | General |
| Category: Hematology | ||||||
| 10/10/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $21.94 | General |
| Category: Hematology | ||||||
| 10/02/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Oncology | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Oncology | ||||||
| 09/17/2024 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 08/06/2024 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 08/06/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $7.99 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $4.22 | General |
| Category: Oncology | ||||||
| 07/03/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: Oncology | ||||||
| 06/05/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $23.03 | General |
| Category: Oncology | ||||||
| 05/09/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $17.36 | General |
| Category: Hematology | ||||||
| 04/10/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $21.47 | General |
| Category: Oncology | ||||||
| 03/14/2024 | Celgene Corporation | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Hematology | ||||||
| 03/10/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $47.01 | General |
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,137.50 | General |
| Category: Oncology | ||||||
| 02/15/2024 | Celgene Corporation | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: Oncology | ||||||
| 12/26/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Consulting Fee | Cash or cash equivalent | $1,137.50 | General |
| Category: Oncology | ||||||
| 11/28/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $910.00 | General |
| Category: Oncology | ||||||
| 11/14/2023 | Novartis Pharmaceuticals Corporation | PIQRAY (Drug), KISQALI | Food and Beverage | In-kind items and services | $27.71 | General |
| Category: Oncology | ||||||
| 10/25/2023 | BeiGene USA, Inc. | BRUKINSA (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $400.00 | General |
| 08/18/2023 | Amgen Inc. | LUMAKRAS (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Oncology | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 499 | 833 | $220,203 | $70,568 |
| 2022 | 9 | 430 | 707 | $172,891 | $60,435 |
| 2021 | 8 | 487 | 736 | $180,234 | $64,928 |
| 2020 | 11 | 536 | 772 | $171,450 | $55,963 |
Total Patients
1,952
Total Services
3,048
Medicare Billing
$251,894
Procedure Codes
38
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 125 | 371 | $107,324 | $37,322 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 139 | $29,902 | $8,899 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 105 | 119 | $17,255 | $5,013 | 29.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 32 | 32 | $13,193 | $4,346 | 32.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 59 | $11,428 | $3,584 | 31.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 24 | 26 | $13,722 | $3,465 | 25.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 26 | 36 | $9,999 | $3,290 | 32.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 28 | 31 | $10,892 | $3,099 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,488 | $1,550 | 23.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 114 | 325 | $89,700 | $33,404 | 37.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 136 | $27,880 | $9,595 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 92 | 103 | $14,111 | $4,478 | 31.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 34 | $11,424 | $3,551 | 31.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $7,486 | $2,719 | 36.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 45 | $8,325 | $2,479 | 29.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 12 | $5,964 | $1,837 | 30.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 18 | 21 | $5,565 | $1,658 | 29.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $2,436 | $713.13 | 29.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 117 | 319 | $88,044 | $34,372 | 39.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 112 | 132 | $27,162 | $9,439 | 34.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 143 | $19,639 | $6,673 | 34.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 36 | 40 | $13,440 | $4,149 | 30.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $9,062 | $3,352 | 37.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 20 | $9,940 | $3,103 | 31.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 34 | 43 | $7,955 | $2,193 | 27.6% |
About Nitin Kapoor
Nitin Kapoor is a Hematology & Oncology healthcare provider based in Washington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013952878.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Nitin Kapoor has received a total of $24,926 in payments from pharmaceutical and medical device companies, with $2,212 received in 2024. These payments were reported across 85 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($16,688).
As a Medicare-enrolled provider, Kapoor has provided services to 1,952 Medicare beneficiaries, totaling 3,048 services with total Medicare billing of $251,894. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Washington, PA
- Active Since 06/17/2006
- Last Updated 09/23/2021
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1013952878
Products in Payments
- CALQUENCE (Drug) $7,161
- Copiktra (Drug) $5,162
- XPOVIO (Drug) $2,250
- VENCLEXTA (Drug) $2,200
- Farydak (Drug) $1,598
- ENHERTU (Biological) $1,138
- IMFINZI (Biological) $1,138
- LYNPARZA (Drug) $940.22
- REBLOZYL (Biological) $173.53
- Cabometyx (Drug) $165.05
- KEYTRUDA (Biological) $145.56
- OPDIVO (Biological) $121.70
- TAGRISSO (Drug) $91.98
- BRUKINSA (Drug) $58.09
- LUMAKRAS (Drug) $54.88
- PADCEV (Biological) $54.12
- MONJUVI (Drug) $49.53
- Tecentriq (Biological) $44.70
- Kyprolis (Drug) $36.36
- KISQALI (Drug) $30.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Washington
Imad Tabbara, M.d, M.D
Hematology & Oncology — Payments: $1.8M
Hematology & Oncology $1.8M
John Marshall
Hematology & Oncology — Payments: $770,250
Hematology & Oncology $770,250
Dr. Catherine Broome, Md, MD
Hematology & Oncology — Payments: $693,161
Hematology & Oncology $693,161
Craig Kessler
Hematology & Oncology — Payments: $632,186
Hematology & Oncology $632,186
Claudine Isaacs
Hematology & Oncology — Payments: $406,847
Hematology & Oncology $406,847
Muhammad Mirza, M.d, M.D
Hematology & Oncology — Payments: $118,419
Hematology & Oncology $118,419